NEW YORK ( TheStreet) -- CHANGE IN RATINGSAnadarko Petroleum ( APC) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. $83 price target. Tronox litigation will likely hang over the stock. AOL ( AOL) upgraded to hold at TheStreet Ratings. Broadcom ( BRCM) upgraded at Auriga from Hold to Buy, Auriga said. $44 price target. Newer WiFi products should help drive near-term growth. CSX ( CSX) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Earnings will be hurt by lower coal volume. Itron ( ITRI) downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse. Valuation call, based on a $50 price target. KLA-Tencor ( KLAC) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Stock is already pricing in higher expected spending in the first half of 2012. Life Technologies ( LIFE) upgraded at Citigroup from Neutral to Buy, Citigroup said. $56 price target. Friday's drop creates positive risk reward. Lam Research ( LRCX) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Valuation call, as the company is already pricing in higher near-term demand. Allscripts ( MDRX) downgraded at Leerink from Outperform to Market Perform, Leerink Swann said. Company will struggle to sustain recent bookings growth. Norfolk Southern ( NSC) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Company is leveraged to lower coal demand. Oracle ( ORCL) downgraded at JMP from Outperform to Market Perform, JMP Securities said. Estimates also cut, as the company may struggle to grow in a cloud computing environment. Pentair ( PNR) added to TPL List at Citigroup to Top Picks Live! at Citigroup. $45 price target. Resi is the new late cycle sentiment. Unum ( UNM) upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. Pricing trends are improving and the company may buy back more stock. Web.com Group ( WWWW) upgraded to hold at TheStreet Ratings.
STOCK COMMENTS / EPS CHANGES
Amerigroup ( AGP) numbers raised at Oppenheimer. Shares of AGP now seen reaching $85, according to Oppenheimer. Estimates also increased on solid 4Q results. Outperform rating. Cree ( CREE) estimates, target increased at Sterne Agee. CREE estimates were raised through 2013, Sterne Agee said. Company is seeing higher sales and better operating leverage. Buy rating and new $40 price target.